Child and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment Landscape
Abstract Introduction Seborrheic dermatitis (SD) is a common, chronic inflammatory skin condition affecting sebaceous gland-rich areas of the skin. The multifactorial etiology of SD involves sebocyte activity, skin microbiome dysbiosis, and immune factors. Various treatment options exist for managem...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-02-01
|
| Series: | Dermatology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s13555-025-01351-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849774428675637248 |
|---|---|
| author | Savanna I. Vidal Nikita Menta Lawrence Green |
| author_facet | Savanna I. Vidal Nikita Menta Lawrence Green |
| author_sort | Savanna I. Vidal |
| collection | DOAJ |
| description | Abstract Introduction Seborrheic dermatitis (SD) is a common, chronic inflammatory skin condition affecting sebaceous gland-rich areas of the skin. The multifactorial etiology of SD involves sebocyte activity, skin microbiome dysbiosis, and immune factors. Various treatment options exist for management of SD. Methods A PubMed search conducted on November 1, 2024 using the terms “seborrheic dermatitis” and “treatment” (restricted to 2019–2024) yielded 389 results, from which relevant papers and additional references were included in this review. Discussion Topical antifungals, topical corticosteroids, and topical calcineurin inhibitors are first-line treatments for SD; however, long-term use of each of these may be limited by varying side effects. Roflumilast foam is a newly approved topical with potential to become a first-line treatment. Myriad systemic treatments exist as second- and third-line treatments for cases of moderate-to-severe and/or recalcitrant SD. Procedural interventions of varying efficacy exist. Conclusions The treatment of SD requires an individualized approach, utilizing a range of topical, systemic, and procedural interventions. The advent of new treatments like roflumilast foam offers novel, well-tolerated, and safer options than what has been available in the past. |
| format | Article |
| id | doaj-art-09fd79330078490f93750bbe5bc21fc0 |
| institution | DOAJ |
| issn | 2193-8210 2190-9172 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Dermatology and Therapy |
| spelling | doaj-art-09fd79330078490f93750bbe5bc21fc02025-08-20T03:01:42ZengAdis, Springer HealthcareDermatology and Therapy2193-82102190-91722025-02-0115359961310.1007/s13555-025-01351-zChild and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment LandscapeSavanna I. Vidal0Nikita Menta1Lawrence Green2Department of Dermatology, George Washington University School of Medicine and Health SciencesDepartment of Dermatology, George Washington University School of Medicine and Health SciencesDepartment of Dermatology, George Washington University School of Medicine and Health SciencesAbstract Introduction Seborrheic dermatitis (SD) is a common, chronic inflammatory skin condition affecting sebaceous gland-rich areas of the skin. The multifactorial etiology of SD involves sebocyte activity, skin microbiome dysbiosis, and immune factors. Various treatment options exist for management of SD. Methods A PubMed search conducted on November 1, 2024 using the terms “seborrheic dermatitis” and “treatment” (restricted to 2019–2024) yielded 389 results, from which relevant papers and additional references were included in this review. Discussion Topical antifungals, topical corticosteroids, and topical calcineurin inhibitors are first-line treatments for SD; however, long-term use of each of these may be limited by varying side effects. Roflumilast foam is a newly approved topical with potential to become a first-line treatment. Myriad systemic treatments exist as second- and third-line treatments for cases of moderate-to-severe and/or recalcitrant SD. Procedural interventions of varying efficacy exist. Conclusions The treatment of SD requires an individualized approach, utilizing a range of topical, systemic, and procedural interventions. The advent of new treatments like roflumilast foam offers novel, well-tolerated, and safer options than what has been available in the past.https://doi.org/10.1007/s13555-025-01351-zSeborrheic dermatitisSeborrheaDandruffTopical antifungalsTopical steroidsTopical calcineurin inhibitors |
| spellingShingle | Savanna I. Vidal Nikita Menta Lawrence Green Child and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment Landscape Dermatology and Therapy Seborrheic dermatitis Seborrhea Dandruff Topical antifungals Topical steroids Topical calcineurin inhibitors |
| title | Child and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment Landscape |
| title_full | Child and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment Landscape |
| title_fullStr | Child and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment Landscape |
| title_full_unstemmed | Child and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment Landscape |
| title_short | Child and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment Landscape |
| title_sort | child and adult seborrheic dermatitis a narrative review of the current treatment landscape |
| topic | Seborrheic dermatitis Seborrhea Dandruff Topical antifungals Topical steroids Topical calcineurin inhibitors |
| url | https://doi.org/10.1007/s13555-025-01351-z |
| work_keys_str_mv | AT savannaividal childandadultseborrheicdermatitisanarrativereviewofthecurrenttreatmentlandscape AT nikitamenta childandadultseborrheicdermatitisanarrativereviewofthecurrenttreatmentlandscape AT lawrencegreen childandadultseborrheicdermatitisanarrativereviewofthecurrenttreatmentlandscape |